The makers of the multiple sclerosis drug Tysabri were dealt a legal setback Tuesday when a federal judge rejected their efforts to move a lawsuit over a patient’s death from state court in Biogen Idec’s Boston backyard to federal court in Iowa.
The decision also is a blow, though perhaps only a fleeting one, for supporters [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment